Curative Labs INC.

Curative Labs INC. was paid $20.31M by Medicaid between Oct 2020 and Dec 2022, across 3 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 76% of everything it billed.

33Billing provider infoCURATIVE LABS INC.
ROUND ROCK, TX 78664

33aNPI1962018374assigned 09/21/2020

33bProvider typeClinical Medical Laboratory

28Total paid$20.31M

24GClaims766,540

24DCodes billed3

24AFirst – last monthOct 2020 – Dec 2022

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#12 of 436

Median peer was paid$17K

This provider vs. median1,177×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	9,176	$79K
2021	338,841	$6.73M
2022	418,523	$13.50M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	76%	401,687	256,471	$15.40M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	22%	345,987	226,130	$4.51M
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	2.0%	18,866	13,635	$398K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTURNER, FREDERICK (CEO)

Same official

Other billing entities under TURNER, FREDERICK

Full network →

Provider	Location	Paid
Curative Labs INC.	Washington, DC	$11.88M
Shield Diagnostics Corp.	San Jose, CA	$27K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.